» Articles » PMID: 35905178

Evidence for a Neuromuscular Circuit Involving Hypothalamic Interleukin-6 in the Control of Skeletal Muscle Metabolism

Abstract

Hypothalamic interleukin-6 (IL6) exerts a broad metabolic control. Here, we demonstrated that IL6 activates the ERK1/2 pathway in the ventromedial hypothalamus (VMH), stimulating AMPK/ACC signaling and fatty acid oxidation in mouse skeletal muscle. Bioinformatics analysis revealed that the hypothalamic IL6/ERK1/2 axis is closely associated with fatty acid oxidation- and mitochondrial-related genes in the skeletal muscle of isogenic BXD mouse strains and humans. We showed that the hypothalamic IL6/ERK1/2 pathway requires the α2-adrenergic pathway to modify fatty acid skeletal muscle metabolism. To address the physiological relevance of these findings, we demonstrated that this neuromuscular circuit is required to underpin AMPK/ACC signaling activation and fatty acid oxidation after exercise. Last, the selective down-regulation of IL6 receptor in VMH abolished the effects of exercise to sustain AMPK and ACC phosphorylation and fatty acid oxidation in the muscle after exercise. Together, these data demonstrated that the IL6/ERK axis in VMH controls fatty acid metabolism in the skeletal muscle.

Citing Articles

Muscle-derived extracellular vesicles mediate crosstalk between skeletal muscle and other organs.

Jia J, Wang L, Zhou Y, Zhang P, Chen X Front Physiol. 2025; 15():1501957.

PMID: 39844898 PMC: 11750798. DOI: 10.3389/fphys.2024.1501957.


IL-6 and diabetic kidney disease.

Zhang L, Xu F, Hou L Front Immunol. 2025; 15:1465625.

PMID: 39749325 PMC: 11693507. DOI: 10.3389/fimmu.2024.1465625.


Dietary protein restriction regulates skeletal muscle fiber metabolic characteristics associated with the FGF21-ERK1/2 pathway.

Li S, Zhong H, Wang Z, Chen J, Huang Z, Zou T iScience. 2024; 27(3):109249.

PMID: 38450157 PMC: 10915561. DOI: 10.1016/j.isci.2024.109249.


Protective Effects of Red Ginseng Against Tacrine-Induced Hepatotoxicity: An Integrated Approach with Network Pharmacology and Experimental Validation.

Kim B, Bak S, Bae S, Jin H, Park S, Kim Y Drug Des Devel Ther. 2024; 18:549-566.

PMID: 38419811 PMC: 10900653. DOI: 10.2147/DDDT.S450305.


Functional role of skeletal muscle-derived interleukin-6 and its effects on lipid metabolism.

Lin W, Song H, Shen J, Wang J, Yang Y, Yang Y Front Physiol. 2023; 14:1110926.

PMID: 37555019 PMC: 10405179. DOI: 10.3389/fphys.2023.1110926.


References
1.
Kwon E, Joung H, Liu S, Chua Jr S, Schwartz G, Jo Y . Optogenetic stimulation of the liver-projecting melanocortinergic pathway promotes hepatic glucose production. Nat Commun. 2020; 11(1):6295. PMC: 7722761. DOI: 10.1038/s41467-020-20160-w. View

2.
Tsuneki H, Tokai E, Nakamura Y, Takahashi K, Fujita M, Asaoka T . Hypothalamic orexin prevents hepatic insulin resistance via daily bidirectional regulation of autonomic nervous system in mice. Diabetes. 2014; 64(2):459-70. DOI: 10.2337/db14-0695. View

3.
Schele E, Benrick A, Grahnemo L, Egecioglu E, Anesten F, Palsdottir V . Inter-relation between interleukin (IL)-1, IL-6 and body fat regulating circuits of the hypothalamic arcuate nucleus. J Neuroendocrinol. 2013; 25(6):580-9. DOI: 10.1111/jne.12033. View

4.
Bobbo V, Jara C, Mendes N, Morari J, Velloso L, Araujo E . Interleukin-6 Expression by Hypothalamic Microglia in Multiple Inflammatory Contexts: A Systematic Review. Biomed Res Int. 2019; 2019:1365210. PMC: 6724433. DOI: 10.1155/2019/1365210. View

5.
Carey A, Steinberg G, Macaulay S, Thomas W, Holmes A, Ramm G . Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase. Diabetes. 2006; 55(10):2688-97. DOI: 10.2337/db05-1404. View